Quantcast
Last updated on April 19, 2014 at 21:20 EDT

Latest Illumina Stories

2013-07-05 23:04:46

Next generation sequencing is set to revolutionize applied markets like diagnostics, drug discovery, biomarker discovery, personalized medicine, and agriculture and animals research. (PRWEB) July 05, 2013 The "Next Generation Sequencing (NGS) Market [Platforms (Illumina HiSeq, MiSeq, Life Technologies Ion Proton/PGM, 454 Roche), Bioinformatics (RNA-Seq, ChIP-Seq), (Pyrosequencing, SBS, SMRT), (Diagnostics, Personalized Medicine)] – Global Forecast to 2017" analyzes and studies...

2013-07-03 23:18:55

“Next Generation Sequencing (NGS) Market [Platforms (Illumina HiSeq, MiSeq, Life Technologies Ion Proton/PGM, 454 Roche), Bioinformatics (RNA-Seq, ChIP-Seq), (Pyrosequencing, SBS, SMRT), (Diagnostics, Personalized Medicine)] – Global Forecast to 2017” is the new market research report added to ReportsnReports.com store. Dallas, Texas (PRWEB) July 03, 2013 The next generation sequencing market is rapidly evolving with a large number of developments taking place to increase accuracy...

2013-06-27 08:29:29

DALLAS, June 27, 2013 /PRNewswire/ -- The Report "Next Generation Sequencing (NGS) Market [Platforms (Illumina HiSeq, MiSeq, Life Technologies Ion Proton/PGM, 454 Roche), Bioinformatics (RNA-Seq, ChIP-Seq), (Pyrosequencing, SBS, SMRT), (Diagnostics, Personalized Medicine)] - Global Forecast to 2017", analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia and Rest of World. Browse - 87 Market Data...

2013-06-26 12:32:47

DUBLIN, June 26, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/mtzjr9/next_generation) has announced the addition of the "Next Generation Sequencing: Market Size, Segmentation, Growth and Trends by Provider 2013" [http://www.researchandmarkets.com/research/mtzjr9/next_generation ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Next generation sequencing (NGS) is a disruptive technology...

2013-06-13 23:17:40

“DNA Sequencing 2013: Market Developments, Growth Areas and Opportunities” and “Global DNA Sequencing Products Market 2012-2016” are new market research reports added to the online library of ReportsnReports.com. Dallas, Texas (PRWEB) June 13, 2013 Biopharm Reports has carried out a global market study of the DNA sequencing field, involving the participation of 233 DNA sequencers and decision-makers in more than 50 countries. This study, now available through...

2013-06-06 08:29:01

- Clontech's SMART(TM) Technology Combined with Rubicon's ThruPLEX(TM) Pre-Analytical Technology Enables Researchers to Conduct High Quality RNA Seq Studies from Very Low Amounts of Total RNA - MOUNTAIN VIEW, Calif. and ANN ARBOR, Mich., June 6, 2013 /PRNewswire/ -- Clontech Laboratories, Inc., a wholly-owned subsidiary of Takara Bio Inc., and Rubicon Genomics, Inc. announced today that they have partnered to integrate Clontech's SMART technology with Rubicon's ThruPLEX technology...

2013-05-20 04:20:57

CAMBRIDGE, Massachusetts, May 20, 2013 /PRNewswire/ -- Genomics Data App now available in BaseSpace Apps Elsevier [http://www.elsevier.com ], a world-leading provider of scientific, medical and technical products and services, announces the launch of the Genomics Data app in collaboration with Illumina, a sequencing and array-based solutions provider for genetics research. The app allows researchers to share large data sets in Illumina's BaseSpace...

2013-03-28 16:25:00

SAN DIEGO, March 28, 2013 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced the appointment of Matt Posard to its Board of Directors. Mr. Posard is currently Senior Vice President and General Manager of Translational & Consumer Genomics at Illumina, Inc. (Logo: http://photos.prnewswire.com/prnh/20100302/LA63139LOGO) "We welcome Matt to our Board of Directors. His strategic marketing experience will complement Halozyme's Board well as we increase our commercial...

2013-03-19 08:27:01

REDWOOD CITY, Calif. and BOSTON, March 19, 2013 /PRNewswire/ -- Ingenuity® Systems, a leading provider of biomedical information and genomics analysis solutions, and GeneInsight®, a wholly owned subsidiary of Partners HealthCare and a leading developer of software to support reporting for genetic testing laboratories, today announced that they will collaborate on an integrated workflow solution, encompassing the annotation, analysis, assessment and reporting of human variants from...

2013-02-12 08:32:01

BALTIMORE, Feb. 12, 2013 /PRNewswire/ -- Exemplar LIMS(TM) has been selected as the primary lab management and electronic lab notebook (ELN) solution for NY Genome Center's laboratory operations. Sapio's LIMS system will initially track next generation sequencing workflows from the Illumina family of sequencers from request through analysis. Support for additional next gen sequencers will be added as needed. Sapio's LIMS software will be deployed on Apple iPads(TM) using Exemplar LIMS for...